ABBVIE INC (4AB.DE) Fundamental Analysis & Valuation

FRA:4AB • US00287Y1091

Current stock price

173.775 EUR
-0.62 (-0.36%)
Last:

This 4AB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 4AB.DE Profitability Analysis

1.1 Basic Checks

  • 4AB had positive earnings in the past year.
  • In the past year 4AB had a positive cash flow from operations.
  • 4AB had positive earnings in each of the past 5 years.
  • Each year in the past 5 years 4AB had a positive operating cash flow.
4AB.DE Yearly Net Income VS EBIT VS OCF VS FCF4AB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • 4AB has a better Return On Assets (3.12%) than 75.31% of its industry peers.
  • 4AB's Return On Invested Capital of 14.42% is amongst the best of the industry. 4AB outperforms 90.12% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 4AB is in line with the industry average of 12.00%.
  • The 3 year average ROIC (12.12%) for 4AB is below the current ROIC(14.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROIC 14.42%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
4AB.DE Yearly ROA, ROE, ROIC4AB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • 4AB has a better Profit Margin (6.84%) than 75.31% of its industry peers.
  • 4AB's Profit Margin has declined in the last couple of years.
  • 4AB has a better Operating Margin (34.23%) than 90.12% of its industry peers.
  • 4AB's Operating Margin has improved in the last couple of years.
  • 4AB's Gross Margin of 71.62% is fine compared to the rest of the industry. 4AB outperforms 62.96% of its industry peers.
  • In the last couple of years the Gross Margin of 4AB has remained more or less at the same level.
Industry RankSector Rank
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
4AB.DE Yearly Profit, Operating, Gross Margins4AB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. 4AB.DE Health Analysis

2.1 Basic Checks

  • 4AB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, 4AB has about the same amount of shares outstanding.
  • Compared to 5 years ago, 4AB has about the same amount of shares outstanding.
  • Compared to 1 year ago, 4AB has a worse debt to assets ratio.
4AB.DE Yearly Shares Outstanding4AB.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
4AB.DE Yearly Total Debt VS Total Assets4AB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • 4AB has an Altman-Z score of 2.27. This is not the best score and indicates that 4AB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 4AB (2.27) is comparable to the rest of the industry.
  • The Debt to FCF ratio of 4AB is 3.79, which is a good value as it means it would take 4AB, 3.79 years of fcf income to pay off all of its debts.
  • 4AB has a better Debt to FCF ratio (3.79) than 83.95% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Altman-Z 2.27
ROIC/WACC1.61
WACC8.94%
4AB.DE Yearly LT Debt VS Equity VS FCF4AB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • 4AB has a Current Ratio of 0.67. This is a bad value and indicates that 4AB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.67, 4AB is not doing good in the industry: 83.95% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.56 indicates that 4AB may have some problems paying its short term obligations.
  • 4AB has a Quick ratio of 0.56. This is amonst the worse of the industry: 4AB underperforms 82.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.56
4AB.DE Yearly Current Assets VS Current Liabilites4AB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 4AB.DE Growth Analysis

3.1 Past

  • 4AB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
  • Measured over the past years, 4AB shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.99% on average per year.
  • The Revenue has grown by 8.57% in the past year. This is quite good.
  • The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%

3.2 Future

  • 4AB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.08% yearly.
  • 4AB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4AB.DE Yearly Revenue VS Estimates4AB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
4AB.DE Yearly EPS VS Estimates4AB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

8

4. 4AB.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.44, the valuation of 4AB can be described as rather expensive.
  • 82.72% of the companies in the same industry are more expensive than 4AB, based on the Price/Earnings ratio.
  • 4AB is valuated rather cheaply when we compare the Price/Earnings ratio to 27.66, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 13.79, which indicates a correct valuation of 4AB.
  • Based on the Price/Forward Earnings ratio, 4AB is valued cheaply inside the industry as 95.06% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.00, 4AB is valued rather cheaply.
Industry RankSector Rank
PE 20.44
Fwd PE 13.79
4AB.DE Price Earnings VS Forward Price Earnings4AB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 4AB indicates a rather cheap valuation: 4AB is cheaper than 82.72% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, 4AB is valued cheaply inside the industry as 91.36% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.3
EV/EBITDA 14.54
4AB.DE Per share data4AB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 4AB has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 4AB's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y28.1%
EPS Next 3Y22.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. 4AB.DE Dividend Analysis

5.1 Amount

  • 4AB has a Yearly Dividend Yield of 3.31%. Purely for dividend investing, there may be better candidates out there.
  • 4AB's Dividend Yield is rather good when compared to the industry average which is at 0.63. 4AB pays more dividend than 97.53% of the companies in the same industry.
  • 4AB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.31%

5.2 History

  • On average, the dividend of 4AB grows each year by 6.76%, which is quite nice.
Dividend Growth(5Y)6.76%
Div Incr Years5
Div Non Decr Years5
4AB.DE Yearly Dividends per share4AB.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 4AB pays out 278.48% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of 4AB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
4AB.DE Yearly Income VS Free CF VS Dividend4AB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
4AB.DE Dividend Payout.4AB.DE Dividend Payout, showing the Payout Ratio.4AB.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

4AB.DE Fundamentals: All Metrics, Ratios and Statistics

ABBVIE INC

FRA:4AB (4/22/2026, 5:29:49 PM)

173.775

-0.62 (-0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners76.21%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap307.37B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target217.08 (24.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.31%
Yearly Dividend5.59
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.23%
PT rev (3m)1.88%
EPS NQ rev (1m)-9.13%
EPS NQ rev (3m)-11.91%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.35%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 20.44
Fwd PE 13.79
P/S 5.91
P/FCF 20.3
P/OCF 19.01
P/B N/A
P/tB N/A
EV/EBITDA 14.54
EPS(TTM)8.5
EY4.89%
EPS(NY)12.6
Fwd EY7.25%
FCF(TTM)8.56
FCFY4.93%
OCF(TTM)9.14
OCFY5.26%
SpS29.39
BVpS-1.57
TBVpS-43.99
PEG (NY)0.42
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROCE 23.09%
ROIC 14.42%
ROICexc 15.28%
ROICexgc N/A
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
FCFM 29.13%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Debt/EBITDA 2.11
Cap/Depr 14.92%
Cap/Sales 1.98%
Interest Coverage 6.97
Cash Conversion 65.45%
Profit Quality 425.61%
Current Ratio 0.67
Quick Ratio 0.56
Altman-Z 2.27
F-Score8
WACC8.94%
ROIC/WACC1.61
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.08%
EBIT Next 3Y19.31%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%

ABBVIE INC / 4AB.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ABBVIE INC (4AB.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 4AB.DE.


What is the valuation status for 4AB stock?

ChartMill assigns a valuation rating of 8 / 10 to ABBVIE INC (4AB.DE). This can be considered as Undervalued.


Can you provide the profitability details for ABBVIE INC?

ABBVIE INC (4AB.DE) has a profitability rating of 7 / 10.


How financially healthy is ABBVIE INC?

The financial health rating of ABBVIE INC (4AB.DE) is 3 / 10.


What is the earnings growth outlook for ABBVIE INC?

The Earnings per Share (EPS) of ABBVIE INC (4AB.DE) is expected to grow by 48.29% in the next year.